DIAFORMIN XR 500 metformin hydrochloride 500 mg extended release tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

metformin hydrochloride, Quantity: 500 mg

Disponibbli minn:

Alphapharm Pty Ltd

Għamla farmaċewtika:

Tablet, modified release

Kompożizzjoni:

Excipient Ingredients: hypromellose; magnesium stearate; carmellose sodium

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

100 Tablets, 30 Tablets, 120 Tablets, 60 Tablets, 10 Tablets (Starter Pack), 90 Tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Diaformin XR 500 may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Sommarju tal-prodott:

Visual Identification: White to off-white, round, biconvex tablet, debossed with 500 on one side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2019-08-08